Simultaneous Measurements of Faecal Calprotectin and the Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Stratify Risk of Relapse | Zendy

Asuka Nakarai | Zendy; Sakiko Hiraoka | Zendy; Sakuma Takahashi | Zendy; Tomoki Inaba | Zendy; Reiji Higashi | Zendy; Motowo Mizuno | Zendy; Shiho Takashima | Zendy; Toshihiro Inokuchi | Zendy; Yuusaku Sugihara | Zendy; Masahiro Takahara | Zendy; Keita Harada | Zendy; Jun Kato | Zendy; Hiroyuki Okada | Zendy

Open Access

Simultaneous Measurements of Faecal Calprotectin and the Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Stratify Risk of Relapse

Author(s) -

Asuka Nakarai,

Sakiko Hiraoka,

Sakuma Takahashi,

Tomoki Inaba,

Reiji Higashi,

Motowo Mizuno,

Shiho Takashima,

Toshihiro Inokuchi,

Yuusaku Sugihara,

Masahiro Takahara,

Keita Harada,

Jun Kato,

Hiroyuki Okada

Publication year - 2017

Publication title -

journal of crohn s and colitis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.277

H-Index - 80

eISSN - 1876-4479

pISSN - 1873-9946

DOI - 10.1093/ecco-jcc/jjx118

Subject(s) - medicine , gastroenterology , confidence interval , calprotectin , faecal calprotectin , hazard ratio , receiver operating characteristic , disease , inflammatory bowel disease

Both faecal calprotectin [Fcal] and the faecal immunochemical test [FIT] are useful to predict clinical relapse of ulcerative colitis [UC]. However, the difference between Fcal and FIT in ability to predict relapse has scarcely been reported. Whether the combined use of these two faecal markers increases the predictability is also unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research